|
|
Blood, 1 February 2007, Vol. 109, No. 3, pp. 1043-1050.
Prepublished online as a Blood First Edition Paper on October 3, 2006; DOI 10.1182/blood-2005-12-024802.
Previous Article | Next Article 
Submitted December 20, 2005
Accepted September 18, 2006
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice
Wai Hon Lim, Svjetlana Kireta, Graeme R Russ, and Patrick TH Coates*
Department of Medicine, The Queen Elizabeth Hospital, Australia
University of Adelaide, Australia
* Corresponding author; email: toby.coates{at}nwahs.sa.gov.au.
Epstein-Barr virus (EBV) is associated with post-transplant lymphoproliferative disease (PTLD),which is a leading cause of cancer death in transplant recipients. We investigated the role of plasmacytoid dendritic cells (PDC) in the development of EBV infection and the onset of lymphoproliferative disease (LPD) in humanized NOD-SCID mice, and studied the effect of EBV on PDC function. NOD-SCID mice reconstituted with PDC-depleted peripheral blood mononuclear cells (PBMC) from EBV IgG+ve human donors had significantly enhanced mortality from disseminated EBV infection (median survival 43 days) compared to PBMC-only mice (median survival 72 days, log rank p-value<0.05). Mice reconstituted with PDC-enriched PBMC challenged with EBV exhibited delayed mortality from EBV-LPD (median survival 80 days) compared to PBMC-only mice challenged with EBV (median survival 50 days, log rank p-value<0.05). EBV-stimulated PDC produced interferon (IFN)- and promoted the activation of NK cells and IFN- -producing CD3+ T cells. PDC activation of CD3+ T cells in response to EBV stimulation was cell-cell contact dependent, in part mediated by toll-like receptor (TLR)-9 signalling that was inhibited by chloroquine and TLR-9 inhibitory CpG. Thus PDC play an important role in anti-EBV cellular immune responses that may be targets for manipulation in novel strategies for the treatment of PTLD.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Iwakiri, L. Zhou, M. Samanta, M. Matsumoto, T. Ebihara, T. Seya, S. Imai, M. Fujieda, K. Kawa, and K. Takada
Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
J. Exp. Med.,
September 28, 2009;
206(10):
2091 - 2099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chetaille, F. Bertucci, P. Finetti, B. Esterni, A. Stamatoullas, J. M. Picquenot, M. C. Copin, F. Morschhauser, O. Casasnovas, T. Petrella, et al.
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
Blood,
March 19, 2009;
113(12):
2765 - 3775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zucchini, G. Bessou, S. H. Robbins, L. Chasson, A. Raper, P. R. Crocker, and M. Dalod
Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection
Int. Immunol.,
January 1, 2008;
20(1):
45 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Guggemoos, D. Hangel, S. Hamm, A. Heit, S. Bauer, and H. Adler
TLR9 Contributes to Antiviral Immunity during Gammaherpesvirus Infection
J. Immunol.,
January 1, 2008;
180(1):
438 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Barry and P. T. H. Coates
Retroviral escape by Friendly infected DCs
Blood,
December 1, 2007;
110(12):
3819 - 3820.
[Full Text]
[PDF]
|
 |
|
|
|